684
Views
63
CrossRef citations to date
0
Altmetric
Articles

Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone

, PhD, , PhD, , PhD, , PhD, , PhD & , PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Maxine Draper, Megan Jean Bester, Mia-Jeanne Van Rooy & Hester Magdalena Oberholzer. (2023) Adverse neurological effects after exposure to copper, manganese, and mercury mixtures in a Spraque-Dawley rat model: an ultrastructural investigation. Ultrastructural Pathology 47:6, pages 509-528.
Read now
Eman N. Hosny, Hussein G. Sawie, Mohamed E. Elhadidy & Yasser A. Khadrawy. (2019) Evaluation of antioxidant and anti-inflammatory efficacy of caffeine in rat model of neurotoxicity. Nutritional Neuroscience 22:11, pages 789-796.
Read now
Manal A. Hamed, Mona A. Mohammed, Asmaa F. Aboul Naser, Azaa A. Matloub, Dalia B. Fayed, Sanaa A. Ali & Wagdy K.B. Khalil. (2019) Optimization of Curcuminoids Extraction for Evaluation Against Parkinson’s Disease in Rats. Journal of Biologically Active Products from Nature 9:5, pages 335-351.
Read now

Articles from other publishers (60)

Imran Kazmi, Muhammad Afzal, Faisal Imam, Sami I. Alzarea, Shaktipal Patil, Amrapali Mhaiskar, Ujashkumar Shah & Waleed Hassan Almalki. (2024) Barbaloin’s Chemical Intervention in Aluminum Chloride Induced Cognitive Deficits and Changes in Rats through Modulation of Oxidative Stress, Cytokines, and BDNF Expression. ACS Omega.
Crossref
Haitham S. Mohammed, Eman N. Hosny, Hussein G. Sawie & Yasser A. Khadrawy. (2023) Transcranial photobiomodulation ameliorates midbrain and striatum neurochemical impairments and behavioral deficits in reserpine-induced parkinsonism in rats. Photochemical & Photobiological Sciences 22:12, pages 2891-2904.
Crossref
Padmini Bisoyi, Deshdeepak Ratna, Gaurav Kumar, Birendra Nath Mallick & Shyamal K. Goswami. (2023) In the Rat Midbrain, SG2NA and DJ-1 have Common Interactome, Including Mitochondrial Electron Transporters that are Comodulated Under Oxidative Stress. Cellular and Molecular Neurobiology 43:7, pages 3061-3080.
Crossref
Amina E. Essawy, Cecil A. Matta, Basant Nabil, Heba-Tallah Abd Elrahim Abd Elkader, Reem Hasaballah Alhasani & Ahmed A. Soffar. (2023) Neuroprotective Effect of Curcumin on the Rat Model of Parkinson’s Disease Induced by Rotenone via Modulating Tyrosine Hydroxylase and Dopa Decarboxylase Expression Levels. Neurochemical Journal 17:3, pages 457-466.
Crossref
Rubina Roy, Rajib Paul, Pallab Bhattacharya & Anupom Borah. (2023) Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology. ACS Chemical Neuroscience 14:16, pages 2830-2848.
Crossref
Jing‐Yi He, Dai‐Di Li, Qian Wen, Ting‐Yang Qin, Hong Long, Shi‐Bin Zhang & Feng Zhang. (2023) Synergistic effects of lipopolysaccharide and rotenone on dopamine neuronal damage in rats. CNS Neuroscience & Therapeutics 29:8, pages 2281-2291.
Crossref
Alisa A. Markina, Rogneda B. Kazanskaya, Julia A. Timoshina, Vladislav A. Zavialov, Denis A. Abaimov, Anna B. Volnova, Tatiana N. Fedorova, Raul R. Gainetdinov & Alexander V. Lopachev. (2023) Na+,K+-ATPase and Cardiotonic Steroids in Models of Dopaminergic System Pathologies. Biomedicines 11:7, pages 1820.
Crossref
Victor Tapias, Paula González-Andrés, Laura F. Peña, Asunción Barbero, Lucía Núñez & Carlos Villalobos. (2023) Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer’s Disease and Parkinson’s Disease. Antioxidants 12:6, pages 1282.
Crossref
Heinz Reichmann. (2022) Koffein, Schokolade und Adenosin A2A Rezeptorantagonisten in der Behandlung des Parkinson Syndroms. Fortschritte der Neurologie · Psychiatrie 91:06, pages 256-261.
Crossref
Engila Khan, Ikramul Hasan & M. Emdadul Haque. (2023) Parkinson’s Disease: Exploring Different Animal Model Systems. International Journal of Molecular Sciences 24:10, pages 9088.
Crossref
Priya Chaudhary, Debasis Mitra, Pradeep K. Das Mohapatra, Anca Oana Docea, Ei Mon Myo, Pracheta Janmeda, Miquel Martorell, Marcello Iriti, Manshuk Ibrayeva, Javad Sharifi-Rad, Antonello Santini, Raffaele Romano, Daniela Calina & William C. Cho. (2023) Camellia sinensis: Insights on its molecular mechanisms of action towards nutraceutical, anticancer potential and other therapeutic applications. Arabian Journal of Chemistry 16:5, pages 104680.
Crossref
Muhammad Shahid Nadeem, Jalaluddin Azam Khan, Fahad A. Al-Abbasi, Shareefa A. AlGhamdi, Amira M. Alghamdi, Nadeem Sayyed, Gaurav Gupta & Imran Kazmi. (2023) Protective Effect of Hirsutidin against Rotenone-Induced Parkinsonism via Inhibition of Caspase-3/Interleukins-6 and 1β. ACS Omega 8:14, pages 13016-13025.
Crossref
Yang Liu, Qiang Wang, Zhen Xie, Dong-Kun Zheng, Jing Li & Gui-Shan Tan. (2023) Lycopodiastrum casuarinoides: An overview of their phytochemicals, biological activities, structure-activity relationship, biosynthetic pathway and 13C NMR data. Fitoterapia 165, pages 105425.
Crossref
Khalid M. Alharthy, Hassan N. Althurwi, Faisal F. Albaqami, Ali Altharawi, Sami I. Alzarea, Fahad A. Al-Abbasi, Muhammad Shahid Nadeem & Imran Kazmi. (2023) Barbigerone Potentially Alleviates Rotenone-Activated Parkinson’s Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines. ACS Omega 8:5, pages 4608-4615.
Crossref
M. A. Nikitina, V. M. Alifirova, E. Yu. Bragina, N. P. Babushkina, D. E. Gomboeva & S. M. Nazarenko. (2023) Environmental and genetic risk factors for Parkinson’s disease. Bulletin of Siberian Medicine 21:4, pages 105-113.
Crossref
Xiaoyan Zhang, Weithye Lee & Jin-Song Bian. (2022) Recent Advances in the Study of Na+/K+-ATPase in Neurodegenerative Diseases. Cells 11:24, pages 4075.
Crossref
Wolfgang H. Jost & Lars Tönges. (2022) Adenosin A2A Rezeptorantagonisten als Therapieoption beim idiopathischen Parkinson-Syndrom?. Fortschritte der Neurologie · Psychiatrie 90:12, pages 565-570.
Crossref
Ali Altharawi, Khalid M. Alharthy, Hassan N. Althurwi, Faisal F. Albaqami, Sami I. Alzarea, Fahad A. Al-Abbasi, Muhammad Shahid Nadeem & Imran Kazmi. (2022) Europinidin Inhibits Rotenone-Activated Parkinson’s Disease in Rodents by Decreasing Lipid Peroxidation and Inflammatory Cytokines Pathways. Molecules 27:21, pages 7159.
Crossref
Jyotsna Asthana & Bhupendra V. Shravage. (2022) Exploring therapeutic potential of mitophagy modulators using Drosophila models of Parkinson’s disease. Frontiers in Aging Neuroscience 14.
Crossref
Matthew ChangJiashu Li, Zeyang Qu, Feng Liu, Hao Jing, Yu Pan, Siyu Guo & Chun Loong Ho. 2022. Principles in Microbiome Engineering. Principles in Microbiome Engineering 1 46 .
Imen Ayed-Boussema, Hiba Hamdi, Hanen Chaabani, Asma M’nassri, Moncef Mokni & Salwa Abid. (2022) Fenpyroximate induced cytotoxicity and genotoxicity in Wistar rat brain and in human neuroblastoma (SH-SY5Y) cells: Involvement of oxidative stress and apoptosis. NeuroToxicology 91, pages 177-187.
Crossref
Damilare Rotimi, Jennifer Chidubem Amanze, Adebola Busola Ojo, Matthew Iyobhebhe, Tobiloba Christiana Elebiyo & Oluwafemi Adeleke Ojo. (2022) Kolaviron, A Biflavonoid Compound: Its Pharmacological Activity and Therapeutic Efficacy. Current Bioactive Compounds 18:5.
Crossref
Jian Zhang, Meng Wang, Yuan Zhao, Yidan Zhang, Ya Gao, Xiangjian Zhang & Guofeng Yang. (2022) Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord. Neuroscience Letters 781, pages 136669.
Crossref
Sunday Solomon Josiah, Courage Dele Famusiwa, Olamide Olajusi Crown, Akeem O. Lawal, Mary Tolulope Olaleye, Afolabi Akintunde Akindahunsi & Afolabi Clement Akinmoladun. (2022) Neuroprotective effects of catechin and quercetin in experimental Parkinsonism through modulation of dopamine metabolism and expression of IL-1β, TNF-α, NF-κB, IκKB, and p53 genes in male Wistar rats. NeuroToxicology 90, pages 158-171.
Crossref
Afolabi C. Akinmoladun, Courage D. Famusiwa, Sunday S. Josiah, Akeem O. Lawal, Mary T. Olaleye & Afolabi A. Akindahunsi. (2022) Dihydroquercetin improves rotenone‐induced Parkinsonism by regulating NF‐κB‐mediated inflammation pathway in rats. Journal of Biochemical and Molecular Toxicology 36:5.
Crossref
Asmaa Fathy Aboul Naser, Wessam Magdi Aziz, Yomna Rashad Ahmed, Wagdy Khalil Bassaly Khalil & Manal Abdel Aziz Hamed. (2022) Parkinsonism-like Disease Induced by Rotenone in Rats: Treatment Role of Curcumin, Dopamine Agonist and Adenosine A2A Receptor Antagonist. Current Aging Science 15:1, pages 65-76.
Crossref
Cheng-Neng Chen, Mao-Hsien Wang, Hung-Sheng Soung, Shu-Mei Chen, Chih-Hsiang Fang, Yi-Wen Lin & Hsiang-Chien Tseng. (2022) L-Theanine Ameliorated Rotenone-Induced Parkinsonism-like Symptoms in Rats. Neurotoxicity Research 40:1, pages 241-258.
Crossref
Nicola Simola, Annalisa Pinna, Lucia Frau, Giulia Costa, Jacopo Marongiu, Pathik Parekh, Marcello Serra & Micaela Morelli. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity 1613 1635 .
Sahar Youssef Al-Okbi, Hoda Bakr Mabrok, Enas Sabry K Al-Siedy, Rasha Salah Mohamed & Asmaa Abdelmohsen Ramadan. (2021) Iron status, immune system, and expression of brain divalent metal transporter 1 and dopamine receptors D1 interrelationship in Parkinson’s disease and the role of grape seed and green coffee bean extracts and quercetin in mitigating the disease in rats. Journal of Herbmed Pharmacology 11:1, pages 63-74.
Crossref
Sonam Gupta, Amit Mishra & Sarika Singh. (2021) Cardinal role of eukaryotic initiation factor 2 (eIF2α) in progressive dopaminergic neuronal death & DNA fragmentation: Implication of PERK:IRE1α:ATF6 axis in Parkinson's pathology. Cellular Signalling 81, pages 109922.
Crossref
Daniel Janitschke, Anna A. Lauer, Cornel M. Bachmann, Heike S. Grimm, Tobias Hartmann & Marcus O. W. Grimm. (2021) Methylxanthines and Neurodegenerative Diseases: An Update. Nutrients 13:3, pages 803.
Crossref
Saeideh Momtaz, Shokoufeh Hassani, Armin Salek Maghsoudi, Amir Hossein Abdolghaffari & Mohammad Abdollahi. 2021. Mitochondrial Physiology and Vegetal Molecules. Mitochondrial Physiology and Vegetal Molecules 413 437 .
Nicola Simola, Annalisa Pinna, Lucia Frau, Giulia Costa, Jacopo Marongiu, Pathik Parekh, Marcello Serra & Micaela Morelli. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity 1 24 .
P. Pramod Kumar & K.V. Harish Prashanth. (2020) Diet with Low Molecular Weight Chitosan exerts neuromodulation in Rotenone induced Drosophila model of Parkinson's disease. Food and Chemical Toxicology 146, pages 111860.
Crossref
Fatemeh Yarmohammadi, A. Wallace Hayes, Nahid Najafi & Gholamreza Karimi. (2020) The protective effect of natural compounds against rotenone‐induced neurotoxicity. Journal of Biochemical and Molecular Toxicology 34:12.
Crossref
Geir Bjørklund, Maryam Dadar, George Anderson, Salvatore Chirumbolo & Michael Maes. (2020) Preventive treatments to slow substantia nigra damage and Parkinson’s disease progression: A critical perspective review. Pharmacological Research 161, pages 105065.
Crossref
Ebenezer O. Farombi, Ifeoluwa O. Awogbindin, Precious D. Olorunkalu, Emmanuel Ogbuewu, Bisola F. Oyetunde, Alberta E. Agedah & Philip A. Adeniyi. (2020) Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson’s disease. Psychopharmacology 237:11, pages 3225-3236.
Crossref
Nema A. Mohammed, Heba M. Abdou, Mona A. Tass, Manal Alfwuaires, Ashraf M. Abdel-Moneim & Amina E. Essawy. (2020) Oral Supplements of Ginkgo biloba Extract Alleviate Neuroinflammation, Oxidative Impairments and Neurotoxicity in Rotenone-Induced Parkinsonian Rats. Current Pharmaceutical Biotechnology 21:12, pages 1259-1268.
Crossref
Attalla Farag El-kott, Ali S. Alshehri, Heba S. Khalifa, Abd-El-karim M. Abd-Lateif, Mohammad Ali Alshehri, Mona M. Abd El-Maksoud, Refaat A. Eid & Mashael Mohammed Bin-Meferij. (2020) Cadmium Chloride Induces Memory Deficits and Hippocampal Damage by Activating the JNK/p 66 Shc/NADPH Oxidase Axis . International Journal of Toxicology 39:5, pages 477-490.
Crossref
Giovanni Schepici, Serena Silvestro, Placido Bramanti & Emanuela Mazzon. (2020) Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease. International Journal of Molecular Sciences 21:13, pages 4766.
Crossref
Yao Lin, Lanfang Tang, Peizhen Huang, Ting Liu, Jianan Zhong, Qian Xu, Xiyu Li, Youning Lin, Shaojian Xiao & Jing Cai. (2020) Mechanisms of Cong Rong Shu Jing Compound Effects on Endoplasmic Reticulum Stress in a Rat Model of Parkinson’s Disease. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-10.
Crossref
Alexandra Kasabova-Angelova, Diana Tzankova, Javor Mitkov, Maya Georgieva, Virginia Tzankova, Alexander Zlatkov & Magdalena Kondeva-Burdina. (2020) Xanthine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson’s Disease. Current Medicinal Chemistry 27:12, pages 2021-2036.
Crossref
Hsiang-Chien Tseng, Mao-Hsien Wang, Kuo-Chi Chang, Hung-Sheng Soung, Chih-Hsiang Fang, Yi-Wen Lin, Keng-Yuan Li, Chih-Chuan Yang & Cheng-Chia Tsai. (2019) Protective Effect of (−)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats. Neurotoxicity Research 37:3, pages 669-682.
Crossref
Tarek K. Motawi, Nermin A. H. Sadik, Manal A. Hamed, Sanaa A. Ali, Wagdy K. B. Khalil & Yomna R. Ahmed. (2019) Potential therapeutic effects of antagonizing adenosine A2A receptor, curcumin and niacin in rotenone-induced Parkinson’s disease mice model. Molecular and Cellular Biochemistry 465:1-2, pages 89-102.
Crossref
Vivek Lawana & Jason R. Cannon. 2020. Neurotoxicity of Pesticides. Neurotoxicity of Pesticides 209 254 .
KG Prakash, BM Bannur, C Madhavrao, Saniya K, S Viveka & M J Sudha. (2019) Anti-Depressant and Neuroprotective Effects of Captopril and Perindopril in Paraquat Model of Parkinsonism. Biomedical and Pharmacology Journal 12:04, pages 1715-1722.
Crossref
Małgorzata Kujawska, Michael Jourdes, Monika Kurpik, Michał Szulc, Hanna Szaefer, Piotr Chmielarz, Grzegorz Kreiner, Violetta Krajka-Kuźniak, Przemyslaw Łukasz Mikołajczak, Pierre-Louis Teissedre & Jadwiga Jodynis-Liebert. (2019) Neuroprotective Effects of Pomegranate Juice against Parkinson’s Disease and Presence of Ellagitannins-Derived Metabolite—Urolithin A—In the Brain. International Journal of Molecular Sciences 21:1, pages 202.
Crossref
Lais S. Rodrigues, Juliane Fagotti, Adriano D.S. Targa, Ana Carolina D. Noseda, Jéssica L. Ilkiwa, Ana Paula Chuproski, Flavia W.C. Dorieux, Patricia D. dos Santos & Marcelo M.S. Lima. (2019) Potential new therapies against a toxic relationship: neuroinflammation and Parkinson’s disease. Behavioural Pharmacology 30:8, pages 675-687.
Crossref
Daniel Pérez-Pérez, Iannel Reyes-Vidal, Elda Georgina Chávez-Cortez, Julio Sotelo & Roxana Magaña-Maldonado. (2019) Methylxanthines: Potential Therapeutic Agents for Glioblastoma. Pharmaceuticals 12:3, pages 130.
Crossref
Stefania Kalampokini, Anouck Becker, Klaus Fassbender, Epameinondas Lyros & Marcus M. Unger. (2019) Nonpharmacological Modulation of Chronic Inflammation in Parkinson’s Disease: Role of Diet Interventions. Parkinson's Disease 2019, pages 1-12.
Crossref
Vera M. Mendes, Margarida Coelho, Angelo R. Tomé, Rodrigo A. Cunha & Bruno Manadas. (2019) Validation of an LC-MS/MS Method for the Quantification of Caffeine and Theobromine Using Non-Matched Matrix Calibration Curve. Molecules 24:16, pages 2863.
Crossref
Briana R De Miranda, Marco Fazzari, Emily M Rocha, Sandra Castro & J Timothy Greenamyre. (2019) Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson’s Disease Incidence. Toxicological Sciences 170:1, pages 133-143.
Crossref
Lucian Del Fabbro, André Rossito Goes, Cristiano Ricardo Jesse, Marcelo Gomes de Gomes, Leandro Cattelan Souza, Fernando V. Lobo Ladd, Aliny A.B. Lobo Ladd, Ricardo Vinicius Nunes Arantes, Astor Reis Simionato, Mauro Schneider Oliveira, Ana Flavia Furian & Silvana Peterini Boeira. (2019) Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson's disease. Neuroscience Letters 706, pages 158-163.
Crossref
Sawsan A. Zaitone, Eman Ahmed, Nehal M. Elsherbiny, Eman T. Mehanna, Mohammed K. El-Kherbetawy, Mohamed H. ElSayed, Duha M. Alshareef & Yasser M. Moustafa. (2019) Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson’s disease therapy. Pharmacological Reports 71:1, pages 32-41.
Crossref
Yao-Wu Fu, Bin Wang, Qi-Zhong Zhang, De-Hai Xu, Yan-Meng Liu, Ting-Long Hou & Shu-Quan Guo. (2019) Efficacy and antiparasitic mechanism of 10-gingerol isolated from ginger Zingiber officinale against Ichthyophthirius multifiliis in grass carp. Veterinary Parasitology 265, pages 74-84.
Crossref
Kimberly C. Paul, Yu‐Hsuan Chuang, I‐Fan Shih, Adrienne Keener, Yvette Bordelon, Jeff M. Bronstein & Beate Ritz. (2019) The association between lifestyle factors and Parkinson's disease progression and mortality. Movement Disorders 34:1, pages 58-66.
Crossref
Dan Cheng, Hongsheng Chang, Suya Ma, Jian Guo, Gaimei She, Feilong Zhang, Lingling Li, Xinjie Li & Yi Lu. (2018) Tiansi Liquid Modulates Gut Microbiota Composition and Tryptophan–Kynurenine Metabolism in Rats with Hydrocortisone-Induced Depression. Molecules 23:11, pages 2832.
Crossref
Shiyuan Wang, Dandan Feng, Yinyin Li, Ying Wang, Xiuping Sun, Xianglei Li, Changlong Li, Zhenwen Chen & Xiaoyan Du. (2018) The different baseline characteristics of cognitive behavior test between Mongolian gerbils and rats. Behavioural Brain Research 352, pages 28-34.
Crossref
Amira M. Soliman, Ahmed M. Fathalla & Ahmed A. Moustafa. (2018) Adenosine role in brain functions: Pathophysiological influence on Parkinson's disease and other brain disorders. Pharmacological Reports 70:4, pages 661-667.
Crossref
Ebenezer Olatunde Farombi, Amos Olalekan Abolaji, Temitope Hannah Farombi, Abiola Surajudeen Oropo, Omowunmi Abigail Owoje & Mathew Terwase Awunah. (2018) Garcinia kola seed biflavonoid fraction (Kolaviron), increases longevity and attenuates rotenone-induced toxicity in Drosophila melanogaster. Pesticide Biochemistry and Physiology 145, pages 39-45.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.